Dr. Alexander Sulakvelidze, Ph.D. is Vice President of R&D and Chief Scientist of Intralytix. He is an internationally recognized expert in phage technology who was instrumental in securing the first ever FDA-approval for phage based food safety product in the World. Dr. Sulakvelidze has published extensively on the subject of phage therapy, including co-editing a major book about bacteriophages entitled “Bacteriophages: Biology and Applications”. He is the author of several issued and pending patents in the field of phage therapy and biocontrol. Dr. Sulakvelidze is currently serving as Editor-in-Chief of the scientific journal Bacteriophage, and as an ad hoc reviewer for several other journals and funding agencies.
Bacteriophages: Biology and Applications